STK11 and neoplasm: Furthermore, some reports have demonstrated that metformin synergizes with first generation TKIs (gefitinib or erlotinib), reducing tumor cell growth and PI3K/AKT/mTOR axis activity in NSCLC cell lines with wild-type Liver Kinase B1 (LKB1) [20].